|
End-of-day quote
Korea S.E.
2026-08-19
|
5-day change | 1st Jan Change | ||
| 20,450.00 KRW | -2.39% |
|
-4.22% | -64.37% |
| 07-23 | Samsung EpiS Unit Signs Cancer Drug Development, Commercialization Deal with IntoCell | MT |
| 12-21 | IntoCell, Inc.(KOSDAQ:A287840) added to S&P Global BMI Index | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.39% | -4.22% | -7.05% | -32.73% | -64.37% | -20.12% | - | - | - | 221M | |
| +0.71% | +1.54% | +2.94% | +18.09% | +8.14% | +1.64% | +23.77% | -23.73% | +210.68% | 50.5B | |
| -0.62% | +4.58% | +15.31% | +45.73% | +169.50% | +487.47% | +624.71% | +772.96% | - | 46.01B | |
| +2.09% | +4.96% | +20.78% | +26.88% | +24.04% | +20.59% | +95.21% | +36.82% | +1,173.18% | 42.85B | |
| +3.85% | +3.13% | +20.86% | +43.94% | +10.59% | +29.60% | +16.50% | -2.88% | +232.15% | 41.03B | |
| -0.72% | -3.91% | +10.41% | +11.67% | +12.60% | +17.87% | +47.98% | -12.88% | +142.51% | 32.02B | |
| +3.04% | +1.89% | +13.12% | +44.86% | +8.30% | +31.62% | +143.62% | +244.69% | +2,032.04% | 16.98B | |
| +4.33% | +1.63% | -0.53% | +9.09% | - | - | - | - | - | 17.05B | |
| +1.61% | +2.34% | +0.90% | +15.49% | +14.97% | +4.24% | +33.44% | -39.98% | +92.20% | 14.3B | |
| +3.87% | +1.98% | +29.26% | +90.25% | +45.38% | +82.99% | +45.80% | -31.01% | +250.83% | 13.84B | |
| +3.26% | +3.18% | +1.46% | +51.91% | -5.34% | -3.98% | -31.10% | -30.05% | +128.04% | 13.31B | |
| -5.28% | +1.15% | +36.56% | +84.01% | +70.42% | +61.55% | +78.26% | -43.57% | - | 12.07B | |
| +0.36% | +0.35% | +0.50% | +59.40% | +23.24% | +32.09% | -7.36% | -39.08% | +170.57% | 11.29B | |
| +4.42% | -0.04% | +22.83% | +20.45% | +31.03% | +762.13% | +1,687.92% | +54.82% | - | 10.78B | |
| +0.58% | -2.53% | -12.02% | +0.97% | -13.70% | +76.10% | +510.46% | +275.09% | +2,446.57% | 10.38B | |
| -1.53% | +1.93% | +9.96% | +57.51% | +77.40% | +175.45% | +709.93% | +221.25% | +1,213.05% | 10.03B | |
| +0.10% | +0.12% | +0.53% | +72.11% | +78.47% | +269.98% | +455.73% | - | - | 10.16B | |
| +4.89% | +11.65% | +9.97% | +62.93% | +63.62% | +199.06% | +545.59% | +144.78% | - | 10.59B | |
| +1.98% | +7.55% | +11.79% | -17.66% | -23.14% | +43.13% | +56.50% | +60.68% | +82.09% | 10.1B | |
| +1.49% | +5.54% | +11.67% | +71.02% | +76.87% | +203.37% | +119.53% | +513.37% | - | 9.29B | |
| Average | +1.30% | +1.80% | +9.96% | +36.80% | +32.00% | +130.25% | +286.47% | +123.60% | +681.16% | 19.14B | |
| Weighted average by Cap. | +1.42% | +2.30% | +11.99% | +36.02% | +41.03% | +125.54% | +226.90% | +140.07% | +586.22% |
- Stock Market
- Stocks
- A287840 Stock
- Sector IntoCell, Inc.
Select your edition
All financial news and data tailored to specific country editions
